AMTX - Aemetis Inc

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, Mar 1, 2021.

Tags:
  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Aemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products primarily through the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol facility in the California Central Valley near Modesto; and a renewable chemical and advanced fuel production facility on the East Coast of India. The company sells biodiesel and refined glycerin to transport companies, resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; and high-grade sanitizer alcohol and various feed products. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

    [​IMG]
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    CUPERTINO, CA, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ: AMTX), a leading producer of below zero carbon intensity dairy Renewable Natural Gas and developer of the “Carbon Zero” renewable jet/diesel biorefineries using negative carbon intensity hydrogen, has rolled out a new five-year plan that positions the company to generate $1.07 billion of revenues and $325 million of adjusted EBITDA in year 2025.

    The Revenues plan is a CAGR of 35% and the EBITDA growth plan is a CAGR of 109% for the years 2021 to 2025.
     

Share This Page